Skip to content

Advertisement

  • Poster presentation
  • Open Access

NT-proBNP, troponin I and troponin T are elevated in ARDS patients without structural heart disease: a single initial reading of cardiac markers is not different from serial daily readings

  • 1,
  • 1,
  • 1 and
  • 1
Critical Care201115 (Suppl 1) :P131

https://doi.org/10.1186/cc9551

  • Published:

Keywords

  • Atrial Fibrillation
  • Pancreatitis
  • Pulmonary Embolism
  • Drug Overdose
  • Road Traffic Accident

Introduction

Myocardial injury and cardiac marker elevation may occur in ARDS patients without a structural heart disease, which might affect cardiac markers [1, 2].

Methods

The study was conducted in Cairo University Hospital between 1 June 2008 and 1 April 2009. The inclusion criterion was any adult patient diagnosed to have ARDS according to the criteria of the American-European Consensus Conference of 1994. Exclusion criteria were any pre-existing structural heart disease, pulmonary embolism, atrial fibrillation, renal insufficiency, age <18. Plasma levels of cardiac markers NT-proBNP, troponin I and troponin T were measured on day 0 and on day 2 and day 7 of ARDS diagnosis. All patients benefited from mechanical ventilation with a lung-protective ventilation strategy according to the NHBLI ARDS Network Treatment Protocol.

Results

The study comprised a total of 20 patients with mean age of 58.9 ± 20.69 years, 11 men versus nine women (P > 0.05). The ARDS aetiology was five (25%) patients due to sepsis, four (20%) due to pneumonia, three (15%) aspiration, three (15%) lung contusions due to road traffic accidents (RTA), two (10%) drug overdose, one (5%) burns, one (5%) pancreatitis, one (5%) drowning. NT-proBNP mean values were 8,903.3 ± 12,852.8 versus 6,083.6 ± 8,467.9 versus 9,914.8 ± 12,574.1 on day 0, day 2 and day 7, respectively (P > 0.05). Troponin I mean values were 3.0 ± 7.7 versus 2.2 ± 6.6 versus 1.5 ± 4.4 on day 0, day 2 and day 7, respectively (P > 0.05). Troponin T mean values were 0.3 ± 0.6 versus 0.6 ± 1.5 versus 0.5 ± 1.1 on day 0, day 2 and day 7, respectively (P > 0.05).

Conclusions

ARDS patients with structurally normal hearts show persistent elevated levels of cardiac markers NT-proBNP, troponin I and troponin T over the first week with no significant change between levels of day 0, day 2 and day 7. A single reading of cardiac markers on any day of the first week of ARDS may not be different from serial daily readings.

Authors’ Affiliations

(1)
Cairo University, Cairo, Egypt

References

  1. Phua J, et al.: B-type natriuretic peptide: issues for the intensivist and pulmonologist. Crit Care Med 2005, 33: 2094.View ArticlePubMedGoogle Scholar
  2. Leuchte , et al.: Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol 2004, 43: 764.View ArticlePubMedGoogle Scholar

Copyright

Advertisement